ArticleOpen medicine (Warsaw, Poland)2025

GATA1: A key biomarker for predicting the prognosis of patients with diffuse large B-cell lymphoma.

Yuxin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.